PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication [PDF]
DEN OpenMallory−Weiss syndrome (MWS) is a common cause of gastroesophageal bleeding. Vomiting increases intra‐abdominal and intra‐esophageal pressures, causing hyperextension of the esophagogastric junction and laceration.
Makoto Higashino +3 more
doaj +9 more sources
Effective management of refractory haematuria using PuraStat: A case report and literature review [PDF]
Urology Case ReportsWe report a case of refractory haematuria successfully managed using intravesical PuraStat®, a synthetic haemostatic agent primarily used in gastrointestinal bleeding.
J. Latham +5 more
doaj +5 more sources
Endoscopic Image 2 Hours after PuraStat® Application: A Case of Achieving Hemostasis Using PuraStat® for Postgastric Lesion Biopsy Bleeding after Hemostatic Clips Failed [PDF]
Case Reports in Gastrointestinal Medicine, 2023 PuraStat® (3D Matrix, Tokyo, Japan) is a novel, self-assembling peptide hemostatic hydrogel that can be used endoscopically. Hemostasis can be physically obtained by covering bleeding points; however, there are no reports of how long PuraStat remains in ...
Yoshitsugu Misumi +2 more
doaj +8 more sources
The Use of PuraStat® in the Management of Walled-Off Pancreatic Necrosis Drained Using Lumen-Apposing Metal Stents: A Case Series [PDF]
Medicina, 2023 Background and Objectives: Bleeding is one of the most feared and frequent adverse events in the case of EUS-guided drainage of WOPN using lumen-apposing metal stents (LAMSs) and of direct endoscopic necrosectomy (DEN).
Cecilia Binda +7 more
doaj +6 more sources
PuraStat for gastrointestinal bleeding management: Effective approach for endoscopic prevention and rescue therapy [PDF]
Endoscopy International OpenElettra Merola +2 more
doaj +8 more sources
The “Dumpling method:” Novel technique for preventing PuraStat migration and enhancing hemostasis [PDF]
Endoscopy International OpenNoriaki Sugawara +6 more
doaj +7 more sources
Hemostasis: Role of PuraStat<sup>®</sup> in the prevention and management of gastrointestinal bleeding. [PDF]
World J Gastrointest EndoscThe management of gastrointestinal (GI) bleeding patients during endoscopy remains a challenge. Hemorrhage is still one of the significant causes of morbidity and even death.
Azer SA.
europepmc +4 more sources
Endoscopic Hemostatic Treatment for Acute Gastrointestinal Bleeding by Combined Modality Therapy with PuraStat and Endoscopic Hemoclips [PDF]
Case Reports in Gastroenterology, 2023 Acute gastrointestinal bleeding (AGIB) is a common condition leading to hospitalization and is associated with significant morbidity and mortality. Various endoscopic treatments have been reported for AGIB, while its endoscopic hemostasis treatment by ...
Kimitoshi Kubo +2 more
doaj +5 more sources
Efficacy and applications for PuraStat<sup>®</sup> use in the management of unselected gastrointestinal bleeding: A retrospective observational study. [PDF]
World J Gastrointest EndoscBACKGROUND Hemostatic powders have been used as primary or salvage therapy to control gastrointestinal bleeding in a number of scenarios. PuraStat® is a novel, self-assembling peptide gel that has properties that differ from hemostatic powders.
Ballester R +4 more
europepmc +5 more sources
Advancement of haemostatic self-assembling peptides in the treatment of gastrointestinal bleeding: What role for PuraStat<sup>®</sup>? [PDF]
World J Gastrointest EndoscPuraStat® is a novel self-assembling peptide (SAP) used as a haemostatic agent in endoscopy, with widespread application in surgical settings. While the current evidence, though deserving further expansion, demonstrates a good haemostatic performance ...
Pellegrino R, Gravina AG.
europepmc +4 more sources